PubRank

B Gaugler

Author PubWeight™ 27.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995 2.88
2 Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res 2000 1.94
3 Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia. Leukemia 2002 1.45
4 A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription. J Exp Med 1999 1.08
5 A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur J Immunol 1996 1.08
6 Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001 1.07
7 Isolation of homologous and heterologous complexes between catalytic and regulatory components of adenylate cyclase by forskolin-Sepharose. FEBS Lett 1983 1.04
8 An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J Exp Med 2001 0.98
9 IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect. Leukemia 2013 0.97
10 Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts. Leukemia 2002 0.96
11 Occurrence of an inhibitory guanine nucleotide-binding regulatory component of the adenylate cyclase system in cyc- variants of S49 lymphoma cells. Eur J Biochem 1983 0.95
12 Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation. Leukemia 2005 0.94
13 Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis. Leukemia 2002 0.93
14 Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia 2012 0.92
15 Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int J Cancer 1996 0.92
16 An antigen recognized by autologous CTLs on a human bladder carcinoma. J Immunol 1998 0.91
17 Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines. Biochem Soc Trans 1995 0.90
18 Inhibition of NS-protein-stimulated human-platelet adenylate cyclase by epinephrine and stable GTP analogs. Eur J Biochem 1983 0.89
19 Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur J Immunol 1999 0.87
20 Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity. Bone Marrow Transplant 2011 0.85
21 ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients. Am J Transplant 2015 0.82
22 Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen. Bone Marrow Transplant 2004 0.80
23 Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report. Bone Marrow Transplant 2001 0.80
24 Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation. Hematology 2002 0.79
25 [Investigation of the viability of radioactively labelled bacteria after adsorption on activated charcoal (author's transl)]. Zentralbl Bakteriol Mikrobiol Hyg A 1981 0.78
26 Dendritic cells: interfaces with immunobiology and medicine. A report from the Keystone Symposia Meeting held in Keystone, 3-8 March 2003. Leukemia 2003 0.76
27 [Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach?]. Transfus Clin Biol 2008 0.75
28 Abundant expression of fibronectin is a major feature of leukemic dendritic cells differentiated from patients with acute myeloid leukemia. Leukemia 2004 0.75